1Suppliers
0Customers
2Debt Items
7Related Chains

Arcutis Biotherapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
THIRD-PARTIES THIRD-PARTIES 90% We rely on third parties to conduct our nonclinical studies and clinical trials, as well as for the manufacturing and supply of our product candidates and for the commercial supply of our products.

Arcutis Biotherapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Arcutis Biotherapeutics, Inc..

Arcutis Biotherapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ARQT-DEBT Debt stack $114.7M 90% Market cache reports total debt of $114.7M.
ARQT-DEBT-7854 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Arcutis Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Arcutis Biotherapeutics, Inc..

Arcutis Biotherapeutics, Inc. Ownership

HolderNameConfidenceEvidence
ARQT-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 272 tracked holders.

Arcutis Biotherapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ARDX Ardelyx, Inc. 100.00 2
STIM Neuronetics, Inc. 100.00 2
GSL Global Ship Lease, Inc. 50.00 2
RZLT Rezolute, Inc. 50.00 2
SLRC SLR Investment Corp. 38.88 1 ['receiving']
TMCI Treace Medical Concepts, Inc. 14.78 2
OM Outset Medical, Inc. 14.78 2